WO2017115752A1 - 自立可能な薬物充填済み合成樹脂製アンプル - Google Patents
自立可能な薬物充填済み合成樹脂製アンプル Download PDFInfo
- Publication number
- WO2017115752A1 WO2017115752A1 PCT/JP2016/088719 JP2016088719W WO2017115752A1 WO 2017115752 A1 WO2017115752 A1 WO 2017115752A1 JP 2016088719 W JP2016088719 W JP 2016088719W WO 2017115752 A1 WO2017115752 A1 WO 2017115752A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- synthetic resin
- drug
- ampoule
- self
- supporting
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/16—Holders for containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
- B65D1/09—Ampoules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
- B65D1/09—Ampoules
- B65D1/095—Ampoules made of flexible material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D11/00—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material
- B65D11/02—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material of curved cross-section
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2207/00—Standing packages
Definitions
- the present invention relates to a drug-filled synthetic resin ampoule that is opened by a breaking operation.
- ampoules and other containers that contain chemicals are made of synthetic resin instead of glass containers from the viewpoint of safety such as breakage at the time of dropping, injury at the time of opening, generation of fragments, and ease of handling. Ampules are being used.
- the ampule made of synthetic resin for example, there is one disclosed in JP2013-095436 (Patent Document 1).
- the ampule made of synthetic resin of Patent Document 1 includes an ampoule body 3 in which a spout 8 is formed, and a plug portion 5 that is connected to the ampoule body 3 through a neck portion 4 formed along the spout 8. And a plastic ampoule 1 having a head portion 7 connected to the plug portion 5 via a thin plate-like edge portion 6 protruding outward from the plug portion 5, a flat shape in a direction intersecting the edge portion 6 The arm plate 15 is formed on the head portion 7.
- the arm plate 15 is picked with a finger, the arm plate 15 is pulled up, the neck portion 4 is bent as a fulcrum, the ampoule body 3 and the head portion 7 are bent, and the neck portion 4 is opened to open the plug. It has become.
- Patent Document 2 JP-A-2014-69856
- the ampule container made of synthetic resin of Patent Document 2 is biaxially stretched and blow-molded into a bottomed cylindrical shape, and is erected on the upper end of the main body portion (1) and the main body portion (1). Formed at the boundary between the main body (1) and the head (6), and is broken by relative fluctuation between the main body (1) and the head (6).
- Patent Documents 1 and 2 Since the synthetic resin ampules of Patent Documents 1 and 2 are formed of synthetic resin, they are not damaged when dropped and are easy to handle. However, in Patent Documents 1 and 2, the ampoule itself is not stable and the opening operation is not easy.
- an object of the present invention is to provide a drug-filled synthetic resin ampoule that can be self-supporting and can be easily opened in a self-supporting state.
- a drug-filled synthetic resin ampoule comprising a self-supporting ampoule body and the drug housed in the ampoule body, wherein the ampoule body is located at an upper part when standing independently
- the hollow portion has a bottom surface portion for self-supporting, and the bottom surface portion includes an extending portion that extends in the predetermined direction of the pressing portion.
- Self-supporting ampule made of drug-filled synthetic resin.
- FIG. 1 is a front view of a drug-filled synthetic resin ampule according to an embodiment of the present invention.
- FIG. 2 is a plan view of the drug-filled synthetic resin ampoule of FIG.
- FIG. 3 is a left side view of the drug-filled synthetic resin ampule of FIG. 4 is a cross-sectional view taken along line AA in FIG.
- FIG. 5 is a plan view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 6 is a plan view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 7 is a plan view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 1 is a front view of a drug-filled synthetic resin ampule according to an embodiment of the present invention.
- FIG. 2 is a plan view of the drug-filled synthetic resin ampoule of FIG.
- FIG. 3 is a left side view of the drug-filled synthetic resin am
- FIG. 8 is a front view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 9 is a plan view of the drug-filled synthetic resin ampoule of FIG.
- FIG. 10 is a left side view of the drug-filled synthetic resin ampule shown in FIG. 11 is a cross-sectional view taken along line BB in FIG.
- FIG. 12 is a longitudinal sectional view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 13 is a longitudinal sectional view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 14 is a longitudinal sectional view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 15 is a front view of a drug-filled synthetic resin ampule according to another embodiment of the present invention.
- FIG. 16 is a plan view of the drug-filled synthetic resin ampoule of FIG.
- FIG. 17 is a right side view of the drug-filled synthetic resin ampoule of FIG. 18 is a bottom view of the drug-filled synthetic resin ampule of FIG.
- FIG. 19 is a perspective view of the drug-filled synthetic resin ampule shown in FIG. 20 is an enlarged cross-sectional view taken along the line CC of FIG.
- FIG. 21 is a bottom view of a cylindrical main body used in the drug-filled synthetic resin ampule shown in FIG. 22 is a top perspective view of the bottom plate member used in the drug-filled synthetic resin ampoule of FIG.
- FIG. 23 is a bottom perspective view of the bottom plate member used in the drug-filled synthetic resin ampule of FIG.
- FIG. 24 is an enlarged view of the vicinity of the breakable portion of the ampule made of synthetic resin filled with drug
- a drug-filled synthetic resin ampule 1 includes an ampoule body 2 that can stand by itself and a drug 6 that is housed in the ampoule body 2.
- the ampoule body 2 includes a distal end portion 3 located at the upper portion when standing independently, a hollow portion 21 having a drug storage portion 23, and a breakable portion 5 provided between the lower portion of the distal end portion 3 and the upper portion of the hollow portion 21.
- the distal end portion 3 includes pressing portions 31 and 32 that guide pressing in a predetermined direction when the breakable portion 5 is broken.
- the hollow portion 21 has a bottom surface portion 4 for self-supporting.
- the bottom surface portion 4 includes extending portions 41 and 42 that extend in predetermined directions (X direction and Y direction) that are induced when the pressing portions 31 and 32 are broken.
- the drug-filled synthetic resin ampoule 1 of the present invention includes an ampoule body 2 that can stand on its own and a drug 6 stored in the ampoule body 2 as shown in FIGS.
- the ampoule body 2 includes a distal end portion 3 that is located at the upper portion when it is self-supporting, a hollow portion 21 having a drug storage portion 23, and a lower portion of the distal end portion 3 and an upper portion of the hollow portion 21. And a breakable portion 5 provided.
- the ampoule main body 2 that can stand by itself includes a cylindrical main body 20 and a bottom plate member 40 that seals the lower end opening of the cylindrical main body 20.
- the cylindrical main body 20 includes a hollow portion 21, a tip portion 3, and a breakable portion 5.
- the cylindrical main body 20 has a lower end opening and extends upward, a distal end portion 3 located at the upper portion of the hollow portion, and between the lower portion of the distal end portion 3 and the upper portion of the hollow portion 21, in other words, the distal end portion. 3 and a breakable portion 5 provided so as to form a boundary portion between the hollow portion 21 and the hollow portion 21.
- the hollow part 21 includes a drug storage part 23.
- the volume of the drug container 23 is preferably about 0.5 to 50 ml.
- the hollow portion 21 includes a cylindrical portion extending a predetermined length with substantially the same outer diameter and inner diameter, and an inner surface tapered portion 22 positioned at the upper portion of the cylindrical portion.
- the hollow portion 21 is provided with an inner tapered portion 22 that is reduced in diameter toward the breakable portion 5.
- the tapered portion 22 may be a tapered portion whose diameter decreases toward the upper portion on both the inner and outer surfaces.
- the cylindrical main body 20 can be formed by injection molding. For example, it is good also as what attaches the breakable part 5 by ultrasonic welding or high frequency welding after shape
- the bottom surface portion 4 may be integrally formed when the cylindrical main body 20 or the cylindrical main body portion including the hollow portion 21 is molded. Similarly to the breakable portion 5, the bottom surface portion 4 may be attached later to the cylindrical main body 20 by ultrasonic welding or high-frequency welding.
- the inner diameter of the cylindrical part is preferably 6 to 33 mm, particularly preferably 7 to 24 mm. Further, the outer diameter of the cylindrical portion is preferably 7 to 35 mm, particularly preferably 10 to 25 mm. As the taper portion 22, the inner diameter of the small diameter portion is preferably 3 to 12 mm, and particularly preferably 3 to 9 mm.
- the hollow part (drug storage part 23) of the cylindrical main body 20 is formed transparent so that the stored drug can be visually observed.
- the drug storage part 23 of the cylindrical main body 20 may be a normal pressure, but may be a reduced pressure or a vacuum state. As described above, when the drug container is in a reduced pressure or vacuum state, the effect of preventing the degradation / degradation of the drug is improved.
- the drug 6 to be stored may be any solid or liquid such as powder or granule.
- Drugs include analgesics such as morphine (narcotic analgesics), insulin, antitumor drugs, cardiotonic drugs, intravenous anesthetics, antiparkinson drugs, ulcer drugs, corticosteroids, arrhythmic drugs, correction electrolytes, antiviruses Drugs, immunostimulants, antibiotics, local anesthetics such as xylocaine, vitamins, multivitamins, various amino acids, antithrombotic agents such as heparin, and the like.
- drugs that require attention in handling and management such as narcotic analgesics and antitumor drugs are preferred.
- the breakable part 5 is a thin fragile part provided in the vicinity of the boundary between the drug storage part 23 and the tip part 3.
- the thin fragile portion (breakable portion) is formed by an annular groove formed on the outer surface of the cylindrical main body 20. Specifically, it is formed on the outer surface of the upper end portion of the tapered portion 22 of the cylindrical main body 20. And if the front-end
- the groove forming portion has a V-shaped cross section. Specifically, the cross-sectional V-shaped angle of the groove forming portion is preferably 30 to 90 °, particularly 40 to 50 °. By producing the groove forming portion at such an angle, when the tip portion 3 is bent, the stress is concentrated at the center of the breakable portion, so that it is surely broken.
- the groove forming portion may have any shape as long as it can be easily broken, and is not limited to the V shape as in the embodiment, and may be a semicircular shape, a semi-elliptical shape, or the like. Moreover, it is good also as making it easy to fracture
- the breakable part may be made of a material more fragile than other parts. Specifically, it is preferable to make an annular shape with a material that can be easily broken only in the vicinity of the breakable portion by multicolor molding, and make the other portions with a material that is not easily broken.
- the groove forming portion is an annular groove forming portion and is provided continuously around the entire outer peripheral surface of the drug storage portion, but is not limited thereto, and may be provided intermittently. .
- edge part on the taper part side and the end part side of the annular groove forming part that forms the breakable part 5 may be chamfered.
- the taper portion side outer edge portion and the tip end side outer surface edge portion may be made to be rounded.
- the tip 3 forms the upper part of the ampoule body 2 and is located at the upper part of the tubular body 20. And the front-end
- the synthetic resin ampoule 1 is preferably self-supporting without wobbling. However, it may be rocked or tilted to some extent. Further, when swinging or tilting, it swings in a first predetermined direction (X direction) or in a direction opposite to the first predetermined direction (Y direction) for a fracture operation of the breakable portion 5 described later. It is preferable that it inclines.
- the bottom surface portion 4 has a substantially flat bottom surface, and the synthetic resin ampule 1 is self-supporting without wobbling in a state where the tip portion 3 is substantially upright.
- the bottom surface portion 4 preferably has a substantially flat bottom surface.
- the bottom surface portion 4 may have a recessed central portion, and has an annular protrusion. , It may be self-supporting.
- the distal end portion 3 is a first pressing portion that guides the pressing in the first predetermined direction (X direction) for the breaking operation of the breakable portion 5.
- 31 and a second pressing portion 32 that guides pressing in a direction opposite to the first predetermined direction (Y direction).
- the bottom surface portion 4 includes an extending portion 41 extending in a predetermined direction (X direction) that is guided when the pressing portion 31 is broken, and the bottom surface portion 4 is guided when the pressing portion 32 is broken.
- An extending portion 42 extending in a predetermined direction (Y direction) is provided.
- the ampoule body 2 can hold a drug, which is a common structure in a glass ampoule, in the upper part of the breakable part 5 including the tip part 3. I don't have a part. For this reason, the drug (particularly the chemical solution) is not scattered at the time of breakage, and the drug does not remain on the broken distal end side.
- the tip portion 3 is a solid tip portion 3. Note that the distal end portion is not completely solid, and may have a lumen portion closed inside.
- the breakable portion 5 is formed by the outer groove portion as described above, and does not constitute the inner surface protruding portion. For this reason, it has no drug reservoir due to the breakable portion.
- the distal end portion 3 includes a plate-like main body portion 34, a plurality of plate-like main body portions 34 that extend along the axial direction on both surfaces and are perpendicular to the plate-like main body portion. With ribs. On the first pressing portion 31 side, ribs 31a, 31b, and 31c extending in the axial direction (vertical direction) are provided. And the 1st press part 31 which induces the press to the fracture
- the first pressing portion 31 is an upper portion of ribs 31a, 31b, and 31c that are provided on the outer surface of the plate-like main body portion 34 and extend in the axial direction (vertical direction). It is formed by.
- the upper portions of the ribs 31a, 31b, and 31c protrude from the plate-shaped main body 34 at substantially the same height. Therefore, the finger can be pressed well, and the pressing direction is a direction orthogonal to the surface (virtual surface) formed by the first pressing portion 31, which is the first predetermined direction (X direction). It has become.
- the distal end portion 3 is pressed in the X direction, and the breakable portion 5 starts to break below the first pressing portion 31. Then, as the breakage proceeds, the tip 3 falls in the X direction.
- the ribs 31 a, 31 b, and 31 c have a protruding length that increases as they extend downward from the pressing portion 31, and form a reinforcing portion in the entire tip portion 3. .
- the 2nd press part 32 which guides the press to the 2nd predetermined direction (Y direction) for the fracture
- the tip 3 has ribs 32a, 32b, and 32c extending in the axial direction (vertical direction) on the second pressing portion 32 side as well as the first pressing portion side. Is provided.
- the second pressing portion 32 is formed at the upper part of ribs 32 a, 32 b, 32 c that are provided on the outer surface of the plate-like main body portion 34 and extend in the axial direction (vertical direction).
- the upper portions of the ribs 32a, 32b, and 32c protrude from the plate-shaped main body 34 at substantially the same height. For this reason, it can press favorably with a finger and the pressing direction becomes a direction orthogonal to the surface (virtual surface) formed by the second pressing portion 32, which is the second predetermined direction (Y direction). It has become.
- the distal end portion 3 is pressed in the Y direction, and the breakable portion 5 starts to break below the second pressing portion 32. Then, as the breakage proceeds, the tip end part falls in the Y direction.
- the ribs 32 a, 32 b, and 32 c have a protruding length that increases as they extend downward from the pressing portion 32, and form a reinforcing portion in the entire tip portion 3.
- the pressing portions 31 and 32 may be only one, and the pressing portion may be formed by a flat plate portion instead of the rib as described above.
- the ampoule body 2 is guided when the pressing part 31 is broken and the extending part 41 extending in a predetermined direction (X direction) guided when the pressing part 31 is broken.
- An extending portion 42 extending in a predetermined direction (Y direction) is provided.
- the extending portions 41 and 42 are formed on the bottom surface portion of the ampoule body 2.
- the bottom surface portion 4 is formed by the bottom plate member 40 and is formed by the bottom plate member 40 of the extending portion.
- the bottom plate member 40 of this embodiment includes a plate-like bottom plate main body and a cylindrical portion 43 extending upward from the upper surface of the bottom plate main body. The cylindrical portion 43 enters the lower end opening 24 of the cylindrical main body 20.
- the baseplate member 40 which forms the bottom face part 4 is provided with the 1st extension part 41 extended to the outer side (radial direction outer side) from the lower end surface of the cylindrical main body 20, as shown in FIG. ing. And this 1st extension part 41 is extended in the 1st predetermined direction (X direction) induced
- the portion 41 serves as a support, and the pressing force applied to the pressing portion 31 can be reliably transmitted to the breakable portion, and the breakable portion is easily broken.
- the bottom plate member 40 forming the bottom surface portion 4 extends outside (in the radial direction) from the lower end surface of the cylindrical main body 20 as shown in FIGS.
- Two extending portions 42 are provided.
- the second extension part 42 is provided so as to face the first extension part 41.
- this 2nd extension part 42 is extended in the 2nd predetermined direction (Y direction) induced
- Y direction 2nd predetermined direction
- the bottom plate member 40 forming the bottom surface portion 4 further extends outward (radially outward) from the lower end surface of the cylindrical main body 20 as shown in FIGS.
- Two extending portions 47 and 48 are provided.
- the extending portions 47 and 48 are provided so as to face each other.
- the extending portions 47 and 48 are provided so as to be substantially orthogonal to the imaginary line connecting the extending portions 31 and 32.
- the outer shape of the bottom surface portion 4 (bottom plate member 40) is rectangular, specifically, substantially square. For this reason, when the ampoule 1 is tilted, the rotation and swinging of the ampoule are restricted.
- the form of the bottom part of the ampule made of a synthetic resin filled with a drug according to the present invention may be similar to the ampule 1a of the embodiment shown in FIG.
- the bottom surface portion 4a includes only two extending portions 41a and 42a facing each other. Similar to the ampoule 1 described above, the extending portion 41a extends in the X direction, and the extending portion 42a extends in the Y direction. The outer edges of the extending portions 41a and 42a are rounded. And the bottom face part 4a of this embodiment has no extension part other than the extension parts 41a and 42a.
- the bottom surface portion 4a is the longest distance portion from the center of the bottom surface portion 4a to the outer edge of the extended portions 41a and 42a to the outer edge from the center of the bottom surface portion 4a. ing. Also in this embodiment, by providing the extending portion, the ampule does not roll when the ampule falls over.
- the form of the bottom portion of the drug-filled synthetic resin ampule of the present invention may be the same as the ampule 1b of the embodiment shown in FIG.
- the bottom surface portion 4b includes only two extending portions 41b and 42b facing each other. Similar to the ampoule 1 described above, the extending portion 41b extends in the X direction, and the extending portion 42b extends in the Y direction. The outer edges of the extending portions 41b and 42b are rounded. And the bottom face part 4b of this embodiment has no extension part other than the extension parts 41b and 42b. Moreover, the extension part 41b has a longer extension length than the extension part 42b.
- the bottom surface portion 4b has the longest distance portion from the center of the bottom surface portion 4b to the outer edge of the extending portion 41b to the outer edge from the center of the bottom surface portion 4b. Also in this embodiment, by providing the extending portion, the ampule does not roll when the ampule falls over.
- the form of the bottom part of the ampule made of synthetic resin filled with the drug of the present invention may be like the ampule 1c of the embodiment shown in FIG.
- the bottom surface portion 4c includes only one extending portion 41c. Similar to the ampoule 1 described above, the extending portion 41c extends in the X direction. The outer edge of the extending portion 41c is rounded. And the bottom face part 4c of this embodiment has no extension part other than the extension part 41c. For this reason, in the ampule 1c of this embodiment, the bottom surface portion 4c has the longest distance portion from the center of the bottom surface portion 4c to the outer edge of the extending portion 41c to the outer edge from the center of the bottom surface portion 4c. . Also in this embodiment, by providing the extending portion, the ampule does not roll when the ampule falls over.
- the tubular main body 20a of the ampule main body 2a includes a hollow portion 21a extending upward, a tip portion 3 positioned at the upper portion of the hollow portion, a lower portion of the tip portion 3 and an upper portion of the hollow portion 21a.
- the breakable portion 5 is provided so as to form a boundary portion between the distal end portion 3 and the hollow portion 21a.
- the cylindrical main body 20a of the ampoule main body 2a is provided with the bulging parts 25 and 26 extended outward from a lower end opening.
- the bottom face part 4d has the extension parts 25a and 26a by the lower surface of these bulging parts 25 and 26. As shown in FIG.
- the cylindrical main body 20a includes a first bulging portion 25 that bulges outward (radially outward) from the lower end.
- the lower surface of the bulging portion 25 is a flat surface, and the first extending portion 25a. Is forming.
- this 1st extension part 25a is extended in the 1st predetermined direction (X direction) induced
- the protruding portion 25a serves as a support, and the pressing force applied to the pressing portion 31 can be reliably transmitted to the breakable portion, and the breakable portion is easily broken.
- the cylindrical main body 20a includes a second bulging portion 26 that bulges outward (radially outward) from the lower end.
- the lower surface of the bulging portion 26 is a flat surface, and the second extension A protruding portion 26a is formed.
- this 2nd extension part 26a is extended in the 2nd predetermined direction (Y direction) induced
- Y direction the pressing portion 32 provided at the tip portion
- the extending portion 26a provided in the cylindrical main body 20a is supported at the time of pressing.
- the pressing force applied to the pressing portion 32 can be reliably transmitted to the breakable portion, and the breakable portion is easily broken.
- the bottom plate member 40a for sealing the lower end opening of the cylindrical main body 20a can be fitted into a recess formed on the lower end surface of the cylindrical main body 20a as shown in FIG. It has a form. Further, the outer edge of the bottom plate member 40a does not reach the outer edge of the cylindrical main body 20a.
- the bottom surface portion 4d includes only two extending portions 25a and 26a (the bulging portions 25 and 26) facing each other. And the bottom face part 4d of this embodiment has no extension part other than the extension parts 25a, 26a. For this reason, in the ampule 1d of this embodiment, the bottom surface portion 4d has the longest distance portion from the center of the bottom surface portion 4d to the outer edge of the extending portions 25a and 26a to the outer edge from the center of the bottom surface portion 4b. ing. In addition, you may provide four extension parts similarly to the ampoule 1 mentioned above. Moreover, only one side like the ampule 1c of the above-described embodiment, specifically, only the bulging portion 25 (extending portion 25a) or only the bulging portion 26 (extending portion 26a) may be used. .
- the bulging portion of the cylindrical main body is shown in FIG.
- the ampule 1e made of a synthetic resin filled with a drug in the embodiment may be a hollow portion.
- the lower end portion of the cylindrical main body 20c is provided with bulging portions 25 and 26 that are hollow and bulge outward.
- the extending portions 25a and 26a are formed by the lower end surface of the bulging portion and the outer edge portion of the bottom plate member 40c.
- the cylindrical main body has a lower bulging portion, like the drug-filled synthetic resin ampule 1f of the embodiment shown in FIG. May be.
- the bulging part may be a hollow part like the ampule 1f of the Example shown in FIG.
- the lower end portion of the cylindrical main body 20b is provided with bulging portions 25 and 26 that are hollow and bulge outward.
- the extension parts 41 and 42 are formed in the lower end surface of the cylindrical main body containing this bulging part by the outer edge part of the mounted baseplate member 40b.
- the bottom plate member has a cone shape inclined toward the center direction of the bottom surface portion of the drug storage portion formed in the bottom plate member.
- An upper surface 45 may be provided.
- the upper surface of the insertion portion 44 into the cylindrical main body is provided with a conical upper surface 45 whose diameter decreases toward the center of the bottom plate member 40d.
- the cone-shaped upper surface may be a polygonal pyramid-shaped upper surface.
- the drug-filled synthetic resin ampoule of the present invention is autoclaved in a state filled with a drug and sealed.
- it is preferably autoclaved at a temperature of 120 ° C. or higher.
- the autoclave sterilization is preferably performed at 121 ° C. for 15 minutes, which is an overkill condition (ISO / TS 17665-2).
- ampule body (cylindrical body and bottom plate member) made of a synthetic resin-filled synthetic resin
- it is preferable that it can be autoclaved.
- it is preferable that it is applicable to the above-mentioned overkill condition (ISO / TS 17665-2).
- rigid polyvinyl chloride polyethylene, polypropylene, polybutadiene, cyclic polyolefin, specifically, ZEONEX (manufactured by Nippon Zeon Co., Ltd.), APEL (manufactured by Mitsui Chemicals, Inc.), Polypropylene homopolymer, polyolefin such as high-density polyethylene, polystyrene, poly- (4-methylpentene-1), polycarbonate, ABS resin, acrylic resin, polymethyl methacrylate (PMMA), polyacetal, polyarylate, polyacrylonitrile, polyfluoride Vinylidene, ionomer, acrylonitrile-butadiene-styrene copolymer, polyester such as polyethylene terephthalate (PET), polybutylene terephthalate (PBT), butadiene-styrene Polymer, various resins such as aromatic or aliphatic polyamide, or
- the drug-filled synthetic resin ampule 10 of this embodiment includes an ampoule body 7 that can stand on its own and a drug 6 that is housed in the ampoule body 7.
- the ampoule body 7 includes a distal end portion 3 that is located at the upper portion when standing independently, a hollow portion 71 having a drug storage portion 78, and a breakable portion 5 provided between the lower portion of the distal end portion 3 and the upper portion of the hollow portion 71.
- the distal end portion 3 includes pressing portions 31 and 32 that guide pressing in a predetermined direction when the breakable portion 5 is broken.
- the hollow portion 71 has a bottom surface portion 9 for self-supporting.
- the bottom surface portion 9 includes extending portions 92a and 92b that extend in predetermined directions (X direction and Y direction) that are guided when the pressing portions 31 and 32 are broken.
- the drug-filled synthetic resin ampule 10 includes a self-supporting ampule body 7 and a drug 6 stored in the ampule body 7 as shown in FIGS.
- the ampoule body 7 is composed of a cylindrical body 70 and a bottom plate member 90 that seals the lower end opening thereof.
- the basic configuration of the drug-filled synthetic resin ampule 10 of this embodiment is the same as that of the drug-filled synthetic resin ampule 1 described above. The main differences are the configuration of the bottom surface portion 9 and the form of the upper portion of the hollow portion 71 of the cylindrical main body 70.
- the ampoule body 7 includes a distal end portion 3 positioned at the upper portion when standing independently, a hollow portion 71 having a drug storage portion 78, and a lower portion of the distal end portion 3 and an upper portion of the hollow portion 71. And a breakable portion 5 provided.
- the ampoule main body 7 that can stand by itself includes a cylindrical main body 70 and a bottom plate member 90 that seals the lower end opening of the cylindrical main body 70.
- the cylindrical main body 70 includes a hollow portion 71, a tip portion 3, and a breakable portion 5.
- the cylindrical main body 70 has a lower end opening and extends upward, a tip portion 3 positioned at the upper portion of the hollow portion, and between the lower portion of the tip portion 3 and the upper portion of the hollow portion 71, in other words, the tip portion. 3 and a breakable portion 5 provided so as to form a boundary portion between the hollow portion 71 and the hollow portion 71.
- the hollow part 71 includes a drug storage part 78.
- the volume of the drug container 78 is preferably about 0.5 to 50 ml.
- the hollow portion 71 includes a cylindrical portion extending a predetermined length with substantially the same outer diameter and inner diameter, and a reduced diameter portion 72 positioned at the upper portion of the cylindrical portion. For this reason, in the ampoule 10 of this embodiment, the hollow portion 71 is reduced in diameter toward the breakable portion 5 both in the inner diameter and the outer diameter.
- the reduced diameter portion 72 includes a curved inner surface portion 72 a that is reduced in diameter while being curved from the distal end of the cylindrical portion, and from the distal end of the curved inner surface portion 72 a to the inner bottom surface 33 of the distal end portion 3.
- a cylindrical inner surface portion 72b extending with substantially the same inner diameter is provided.
- the breakable portion 5 is located at the cylindrical inner surface portion 72b, particularly at an upper portion of the cylindrical inner surface portion 72b (a portion close to the inner bottom surface 33 of the tip portion 3).
- the cylindrical main body 70 can be formed by injection molding.
- the bottom plate member 90 is attached later to the cylindrical main body 70 by ultrasonic welding or high frequency welding.
- the inner diameter of the cylindrical portion of the cylindrical main body 70 is preferably 6 to 33 mm, and particularly preferably 7 to 24 mm. Further, the outer diameter of the cylindrical portion is preferably 7 to 35 mm, particularly preferably 10 to 25 mm.
- the inner diameter of the cylindrical inner surface portion 72b is preferably 3 to 12 mm, and particularly preferably 3 to 9 mm.
- the hollow part (drug storage part 78) of the cylindrical main body 70 is formed transparent so that the stored drug can be visually observed. Further, the drug storage portion 78 of the cylindrical main body 70 may be at normal pressure, but may be in a reduced pressure or vacuum state when the resin has gas barrier properties. As described above, when the drug container is in a reduced pressure or vacuum state, the effect of preventing the degradation / degradation of the drug is improved. As the medicine 6 to be stored, those described above are used.
- the breakable portion 5 is a thin fragile portion provided in the vicinity of the boundary between the drug storage portion 78 and the distal end portion 3.
- the thin fragile portion (breakable portion) is formed by an annular groove formed on the outer surface of the cylindrical main body 70. Specifically, it is formed on the outer surface of the upper end portion of the reduced diameter portion 72 of the cylindrical main body 70. And if the front-end
- the groove forming portion has a V-shaped cross section.
- the cross-sectional V-shaped angle of the groove forming portion is preferably 30 to 90 °, particularly 50 to 70 °.
- the thickness of the cylindrical main body 70 in the breakable portion 5 is preferably 0.05 to 0.5 mm, and particularly preferably 0.1 to 0.4 mm.
- the breakable portion and the groove forming portion may have any shape as long as they are easily breakable, and are not limited to the V-shape as in the embodiment, but are semicircular, semielliptical, etc. Also good. Moreover, it is good also as making it easy to fracture
- the breakable part may be made of a material more fragile than other parts. Specifically, it is preferable to make an annular shape with a material that can be easily broken only in the vicinity of the breakable portion by multicolor molding, and make the other portions with a material that is not easily broken.
- the groove forming portion is an annular groove forming portion and is provided continuously around the entire outer peripheral surface of the drug storage portion, but is not limited thereto, and may be provided intermittently. .
- tip part may be chamfered. Specifically, the taper portion side outer edge portion and the tip end side outer surface edge portion may be made to be rounded.
- the tip 3 forms the upper part of the ampoule body 7 and is located at the upper part of the tubular body 70. And the front-end
- the ampule 10 of this embodiment has a bottom surface portion 9 for self-supporting.
- the synthetic resin ampoule 10 has the bottom surface portion 9 so that the upper portion of the hollow portion faces upward and the distal end portion 3 also stands on its own with its distal end facing upward.
- the synthetic resin ampoule 10 is preferably self-supporting without wobbling. Further, when swinging or tilting, it swings in a first predetermined direction (X direction) or in a direction opposite to the first predetermined direction (Y direction) for a fracture operation of the breakable portion 5 described later. It is preferable that it inclines.
- the tip portion 3 is pressed in the X direction, and the breakable portion 5 starts to break below the first pressing portion 31. Then, as the breakage proceeds, the tip 3 falls in the X direction.
- the tip portion 3 is pressed in the Y direction, and the breakable portion 5 starts to break below the second pressing portion 32. Then, as the break progresses, the tip 3 falls down in the Y direction.
- the bottom surface portion 9 includes an extension portion 92a that extends in a predetermined direction (Y direction) that is induced when the pressing portion 32 of the tip portion 3 is broken, and the tip portion 3 is pressed.
- the bottom surface portion 9 is formed by the bottom plate member 90 and the flange portion 73 provided at the lower end 77 of the cylindrical main body 70.
- the ampoule body 7 seals the outwardly extending flange portion 73 provided at the lower end 77 of the hollow portion and the opening of the lower end 77 of the hollow portion, and the flange. And a bottom plate member 90 whose upper surface is in contact with the lower surface of the portion 73. Since the bottom surface portion 9 is composed of the flange portion and the bottom plate member 90 laminated thereon, the bottom surface portion 9 has sufficient strength and rigidity.
- the flange portion 73 of the cylindrical main body 70 is provided so as to extend outward from the lower end 77 of the outer cylindrical main body 70, and has a disk shape. Also.
- the flange portion 73 has a substantially uniform thickness.
- the flange part 73 is equipped with two recessed parts 74a and 74b which face each other.
- the recesses 74a and 74b are wavy recesses.
- the flange portion 73 includes two curved corner portions 75a and 75b facing each other. And the outer edge which connects recessed part 74a, 74b of the flange part 73 and curved corner
- angular part 75a, 75b is extended substantially linearly. Therefore, the flange portion 73 is a rectangular plate-shaped flange portion, and one set of corner portions facing each other includes a concave portion, and the other corner portion facing each other includes a curved corner portion.
- the baseplate member 90 is provided with the extension part 92a, 92b located in the corner
- the extending portion 92a extends in a predetermined direction (Y direction) that is induced when the pressing portion 32 of the distal end portion 3 is broken.
- the extending portion 92b extends in a predetermined direction (X direction) that is guided when the pressing portion 31 of the distal end portion 3 is broken.
- the extending portions 92a and 92b are protruding portions that protrude upward. Specifically, the extending portions 92a and 92b form a substantially heart-shaped protrusion having a central concave portion facing each other.
- the extending portions 92a and 92b have bulged portions formed on both sides of the central recess.
- the extension 92 a is engaged with the recess 74 a of the flange 73
- the extension 92 b is engaged with the recess 74 b of the flange 73.
- the bottom plate member 90 of this embodiment includes an annular rib 95 formed on the upper surface of the substrate portion 91 as shown in FIG. As shown in FIG. 20, the annular rib 95 enters and engages in the opening at the lower end 77 of the cylindrical main body 70. Further, when the bottom plate member 90 is ultrasonically fused to the flange portion 73 (opening portion of the lower end 77) of the cylindrical main body 70, the annular rib 95 can be used as an ultrasonic sealing rib.
- the bottom plate member 90 of this embodiment includes a central annular lower rib 93 formed on the lower surface of the substrate portion 91 and corner lower ribs 94a, 94b, 94c formed at the respective corners. , 94d.
- the lower surfaces of the central annular lower rib 93 and the corner lower ribs 94a, 94b, 94c, 94d are formed to be substantially on the same plane.
- An annular rib 95 is located above the central annular lower rib 93.
- an extension 92a is positioned above the corner lower rib 94a
- an extension 92b is positioned above the corner lower rib 94b.
- the bottom plate portion 9 is formed by laminating the flange portion 73 of the cylindrical main body 70 on the upper surface of the bottom plate member 90. Also in the ampule 10 of this embodiment, the outer shape of the bottom surface portion 9 (bottom plate member 90) is rectangular, specifically, substantially square. For this reason, the rotation and swinging of the ampoule when the ampoule 90 is overturned are restricted. In addition, since the corners are all rounded, there is no pain to the operator when holding the ampoule.
- the self-supporting ampule made of a synthetic resin filled with a resin according to the present invention is as follows.
- a drug-filled synthetic resin ampoule, the synthetic resin ampoule comprising a self-supporting ampoule body and the drug housed in the ampoule body, wherein the ampoule body is upper
- a distal end portion located at the top a hollow portion having a drug storage portion, and a breakable portion provided between a lower portion of the distal end portion and an upper portion of the hollow portion, wherein the distal end portion breaks the breakable portion.
- a pressing portion that guides pressing in a predetermined direction during operation wherein the hollow portion has a bottom surface portion for self-supporting, and the bottom surface portion includes an extending portion that extends in the predetermined direction of the pressing portion.
- this drug-filled synthetic resin ampoule has a bottom surface portion for self-supporting, and the bottom surface portion includes an extending portion extending in a predetermined direction of the pressing portion.
- the front end portion induces a pressing in a direction opposite to the first predetermined direction, and a first pressing portion for inducing a pressing operation in the first predetermined direction for the breaking operation of the breakable portion.
- a second pressing portion, and the bottom surface portion includes a first extending portion extending in the first predetermined direction and a second extending portion extending in the opposite direction.
- a self-supporting ampule made of a synthetic resin filled with a resin as described in (1).
- the ampoule body does not have a part capable of retaining a drug in an upper part of the breakable part including the tip part, and is a self-supporting drug-filled composition according to the above (1) or (2) Resin ampoule.
- the distance from the center of the bottom surface portion to the outer edge of the extending portion is the longest distance portion from the center of the bottom surface portion to the outer edge.
- the ampule body is a self-supporting drug-filled synthetic resin ampule according to any one of (1) to (4), wherein the ampule body includes a bottom plate member that seals the lower end opening of the hollow portion.
- the extension portion is a self-supporting drug-filled synthetic resin ampule according to (5) or (6) provided on the bottom plate member.
- the ampoule body includes a flange portion extending outwardly provided at a lower end opening of the hollow portion and a bottom plate whose upper surface is in contact with the lower surface of the flange portion while sealing the lower end opening of the hollow portion.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Hematology (AREA)
- Ceramic Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Containers Opened By Tearing Frangible Portions (AREA)
Abstract
Description
しかし、特許文献1および2のものでは、アンプル自体の安定性が悪く、開栓操作が、容易なものではなかった。
薬物充填済み合成樹脂製アンプルであって、前記合成樹脂製アンプルは、自立可能なアンプル本体と、前記アンプル本体内に収納された前記薬物とを備え、前記アンプル本体は、自立時に上部に位置する先端部と、薬物収納部を有する中空部と、前記先端部の下部と前記中空部の上部間に設けられた破断可能部とを備え、前記先端部は、前記破断可能部の破断操作時に所定方向への押圧を誘導する押圧部を備え、前記中空部は、自立のための底面部を有し、前記底面部は、前記押圧部の前記所定方向に延出する延出部を備えている自立可能な薬物充填済み合成樹脂製アンプル。
本発明の薬物充填済み合成樹脂製アンプル1は、自立可能なアンプル本体2と、アンプル本体2内に収納された薬物6とを備える。アンプル本体2は、自立時に上部に位置する先端部3と、薬物収納部23を有する中空部21と、先端部3の下部と中空部21の上部間に設けられた破断可能部5とを備える。先端部3は、破断可能部5の破断操作時に所定方向への押圧を誘導する押圧部31、32を備える。中空部21は、自立のための底面部4を有する。底面部4は、押圧部31,32の破断操作時に誘導される所定方向(X方向,Y方向)に延出する延出部41,42を備えている。
なお、押圧部31,32は、一方のみでもよく、また、押圧部は、上述したようなリブではなく、平板部により形成してもよい。
延出部41,42は、アンプル本体2の底面部に形成されている。図1ないし図4に示す実施例のアンプル1では、底面部4は、底板部材40により形成されており、延出部の底板部材40により形成されている。この実施例の底板部材40は、図4に示すように、板状の底板本体と、底板本体の上面より、上方に延びる筒状部43を備えている。筒状部43は、筒状本体20の下端開口24内に、進入している。
この実施例の薬物充填済み合成樹脂製アンプル1dと上述した実施例のアンプル1との相違は、底面部の形成形態、具体的には、筒状本体の下部形態および底板部材の形態のみであり、その他の部分については、同じである。同じ符号を付した部分については、上述した説明を参照する。
本合成樹脂製アンプル本体は、前述の通り、射出成型にて成形されるものであり、射出成形に適した硬質の各種樹脂材料を用いることが好ましい。
この実施例の薬物充填済み合成樹脂製アンプル10は、自立可能なアンプル本体7と、アンプル本体7内に収納された薬物6とを備える。アンプル本体7は、自立時に上部に位置する先端部3と、薬物収納部78を有する中空部71と、先端部3の下部と中空部71の上部間に設けられた破断可能部5とを備える。先端部3は、破断可能部5の破断操作時に所定方向への押圧を誘導する押圧部31、32を備える。中空部71は、自立のための底面部9を有する。底面部9は、押圧部31,32の破断操作時に誘導される所定方向(X方向,Y方向)に延出する延出部92a,92bを備えている。
また、上述したすべての実施例を含め、溝形成部の断面V字角度は、30~90°、特に、50~70°であることが好ましい。このような角度に溝形成部を作製することにより、先端部3を折り曲げた際、破断可能部の中心に応力が集中して確実に破断するものとなる。また、破断可能部5における筒状本体70の肉厚は、0.05~0.5mmが好ましく、特に、0.1~0.4mmが好ましい。
先端部3は、アンプル本体7の上部を形成しており、また、筒状本体70の上部に位置している。そして、先端部3は、破断可能部5の破断操作時に所定方向への押圧を誘導する押圧部31、32を備える。先端部3については、上述した合成樹脂製アンプル1にて説明したものと同じである。
この実施例のアンプル10では、底板部材90と筒状本体70の下端77に設けられたフランジ部73により、底面部9が形成されている。具体的には、この実施例のアンプル10では、アンプル本体7は、中空部の下端77に設けられた外方に延びるフランジ部73と、中空部の下端77の開口を封止するとともに、フランジ部73の下面に上面が当接した底板部材90とを備えている。底面部9が、フランジ部とそれと積層された底板部材90により構成されているので、底面部9は、十分な強度および剛性を備えている。
(1) 薬物充填済み合成樹脂製アンプルであって、前記合成樹脂製アンプルは、自立可能なアンプル本体と、前記アンプル本体内に収納された前記薬物とを備え、前記アンプル本体は、自立時に上部に位置する先端部と、薬物収納部を有する中空部と、前記先端部の下部と前記中空部の上部間に設けられた破断可能部とを備え、前記先端部は、前記破断可能部の破断操作時に所定方向への押圧を誘導する押圧部を備え、前記中空部は、自立のための底面部を有し、前記底面部は、前記押圧部の前記所定方向に延出する延出部を備えている自立可能な薬物充填済み合成樹脂製アンプル。
(2) 前記先端部は、前記破断可能部の破断操作用かつ第1の所定方向への押圧を誘導する第1の押圧部と、前記第1の所定方向と反対方向への押圧を誘導する第2の押圧部とを備え、前記底面部は、前記第1の所定方向に延出する第1の延出部と、前記反対方向に延出する第2の延出部を備えている上記(1)に記載の自立可能な薬物充填済み合成樹脂製アンプル。
(3) 前記アンプル本体は、前記先端部を含む前記破断可能部より上部部分に、薬物を保留可能な部分を持っていない上記(1)または(2)に記載の自立可能な薬物充填済み合成樹脂製アンプル。
(4) 前記底面部は、前記底面部の中央から前記延出部の外縁までの距離が、前記底面部の中央からの外縁までの最長距離部となっている上記(1)ないし(3)のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
(5) 前記アンプル本体は、前記中空部の下端開口を封止する底板部材を備えている上記(1)ないし(4)のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
(6) 前記底板部材は、前記底板部材内に形成された前記薬物収納部の底面部の中心方向に向かって傾斜する錐体状上面を備えている上記(5)に記載の自立可能な薬物充填済み合成樹脂製アンプル。
(7) 前記延出部は、前記底板部材に設けられている上記(5)または(6)に記載の自立可能な薬物充填済み合成樹脂製アンプル。
(8) 前記延出部は、前記中空部の下端部に設けられている上記(1)ないし(6)のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
(9) 前記中空部は、前記破断可能部に向かって、縮径する内面テーパー部を備えている上記(1)ないし(8)のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
(10) 前記アンプル本体は、前記中空部の下端開口に設けられた外方に延びるフランジ部と、前記中空部の下端開口を封止するとともに、前記フランジ部の下面に上面が当接した底板部材とを備えている上記(1)ないし(4)のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
Claims (10)
- 薬物充填済み合成樹脂製アンプルであって、
前記合成樹脂製アンプルは、自立可能なアンプル本体と、前記アンプル本体内に収納された前記薬物とを備え、
前記アンプル本体は、自立時に上部に位置する先端部と、薬物収納部を有する中空部と、前記先端部の下部と前記中空部の上部間に設けられた破断可能部とを備え、
前記先端部は、前記破断可能部の破断操作時に所定方向への押圧を誘導する押圧部を備え、前記中空部は、自立のための底面部を有し、前記底面部は、前記押圧部の前記所定方向に延出する延出部を備えていることを特徴とする自立可能な薬物充填済み合成樹脂製アンプル。 - 前記先端部は、前記破断可能部の破断操作用かつ第1の所定方向への押圧を誘導する第1の押圧部と、前記第1の所定方向と反対方向への押圧を誘導する第2の押圧部とを備え、前記底面部は、前記第1の所定方向に延出する第1の延出部と、前記反対方向に延出する第2の延出部を備えている請求項1に記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記アンプル本体は、前記先端部を含む前記破断可能部より上部部分に、薬物を保留可能な部分を持っていない請求項1または2に記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記底面部は、前記底面部の中央から前記延出部の外縁までの距離が、前記底面部の中央からの外縁までの最長距離部となっている請求項1ないし3のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記アンプル本体は、前記中空部の下端開口を封止する底板部材を備えている請求項1ないし4のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記底板部材は、前記底板部材内に形成された前記薬物収納部の底面部の中心方向に向かって傾斜する錐体状上面を備えている請求項5に記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記延出部は、前記底板部材に設けられている請求項5または6に記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記延出部は、前記中空部の下端部に設けられている請求項1ないし6のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記中空部は、前記破断可能部に向かって、縮径する内面テーパー部を備えている請求項1ないし8のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
- 前記アンプル本体は、前記中空部の下端開口に設けられた外方に延びるフランジ部と、前記中空部の下端開口を封止するとともに、前記フランジ部の下面に上面が当接した底板部材とを備えている請求項1ないし4のいずれかに記載の自立可能な薬物充填済み合成樹脂製アンプル。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017559182A JP7075761B2 (ja) | 2015-12-28 | 2016-12-26 | 自立可能な薬物充填済み合成樹脂製アンプル |
EP16881727.8A EP3398581B1 (en) | 2015-12-28 | 2016-12-26 | Self-standing drug-filled synthetic resin ampule |
AU2016381925A AU2016381925B2 (en) | 2015-12-28 | 2016-12-26 | Self-standing drug-filled synthetic resin ampule |
US16/020,249 US10912713B2 (en) | 2015-12-28 | 2018-06-27 | Self-standing drug-filled synthetic resin ampule |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015256887 | 2015-12-28 | ||
JP2015-256887 | 2015-12-28 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/020,249 Continuation US10912713B2 (en) | 2015-12-28 | 2018-06-27 | Self-standing drug-filled synthetic resin ampule |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017115752A1 true WO2017115752A1 (ja) | 2017-07-06 |
Family
ID=59225142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2016/088719 WO2017115752A1 (ja) | 2015-12-28 | 2016-12-26 | 自立可能な薬物充填済み合成樹脂製アンプル |
Country Status (5)
Country | Link |
---|---|
US (1) | US10912713B2 (ja) |
EP (1) | EP3398581B1 (ja) |
JP (1) | JP7075761B2 (ja) |
AU (1) | AU2016381925B2 (ja) |
WO (1) | WO2017115752A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019181978A1 (ja) | 2018-03-23 | 2019-09-26 | テルモ株式会社 | 薬物充填済み合成樹脂製アンプルおよびそれに使用される合成樹脂製アンプル本体 |
JP2020059550A (ja) * | 2018-10-12 | 2020-04-16 | ロート製薬株式会社 | 樹脂製容器 |
JP7360238B2 (ja) | 2018-10-12 | 2023-10-12 | ロート製薬株式会社 | 樹脂製のブロー・フィル・シール成形容器 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59169832U (ja) * | 1983-04-27 | 1984-11-13 | 大成化工株式会社 | アンプル |
JPH08322908A (ja) * | 1995-05-29 | 1996-12-10 | One Fuoot:Kk | 開封口を二重構造とした樹脂製アンプル |
WO2007141813A1 (en) * | 2006-06-08 | 2007-12-13 | Bisio Progetti S.P.A. | Improved s ingle-dose vessel, and process and machine for manufacturing it |
WO2008056442A1 (en) * | 2006-11-07 | 2008-05-15 | Yoshio Oyama | Mechanism capable of providing neat cleaved opening surface and ampule with movable gasket |
JP2013095436A (ja) | 2011-10-28 | 2013-05-20 | Otsuka Pharmaceut Factory Inc | プラスチックアンプル |
JP2014069856A (ja) | 2012-09-28 | 2014-04-21 | Yoshino Kogyosho Co Ltd | 合成樹脂製アンプル容器 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917120A (en) * | 1971-11-11 | 1975-11-04 | Merck Patent Gmbh | Single use container for liquid pharmaceutical compositions |
DE19648820A1 (de) * | 1996-11-26 | 1998-05-28 | Dentaco Gmbh | Kunststoffampulle |
IT1316905B1 (it) * | 2000-06-15 | 2003-05-13 | Lameplast Spa | Contenitore richiudibile particolarmente per prodotti fluidi. |
US6619516B2 (en) * | 2002-02-05 | 2003-09-16 | Weiler Engineering, Inc. | Hermetically sealed container with unitary drop-dispenser |
DK2266521T3 (da) * | 2008-03-14 | 2013-10-28 | Otsuka Pharma Co Ltd | Plastikampul |
IT1401173B1 (it) * | 2010-07-26 | 2013-07-12 | Lameplast Spa | Contenitore richiudibile per prodotti fluidi, particolarmente per prodotti medicali, farmaceutici e cosmetici |
JP5904441B2 (ja) | 2012-04-27 | 2016-04-13 | 株式会社吉野工業所 | 合成樹脂製アンプル容器 |
JP5802605B2 (ja) | 2012-04-27 | 2015-10-28 | 株式会社吉野工業所 | 樹脂製アンプル |
PL2826457T3 (pl) * | 2013-07-16 | 2016-11-30 | Ampułka dla cieczy medycznej i sposób wytwarzania ampułki |
-
2016
- 2016-12-26 AU AU2016381925A patent/AU2016381925B2/en active Active
- 2016-12-26 WO PCT/JP2016/088719 patent/WO2017115752A1/ja active Application Filing
- 2016-12-26 JP JP2017559182A patent/JP7075761B2/ja active Active
- 2016-12-26 EP EP16881727.8A patent/EP3398581B1/en active Active
-
2018
- 2018-06-27 US US16/020,249 patent/US10912713B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59169832U (ja) * | 1983-04-27 | 1984-11-13 | 大成化工株式会社 | アンプル |
JPH08322908A (ja) * | 1995-05-29 | 1996-12-10 | One Fuoot:Kk | 開封口を二重構造とした樹脂製アンプル |
WO2007141813A1 (en) * | 2006-06-08 | 2007-12-13 | Bisio Progetti S.P.A. | Improved s ingle-dose vessel, and process and machine for manufacturing it |
WO2008056442A1 (en) * | 2006-11-07 | 2008-05-15 | Yoshio Oyama | Mechanism capable of providing neat cleaved opening surface and ampule with movable gasket |
JP2013095436A (ja) | 2011-10-28 | 2013-05-20 | Otsuka Pharmaceut Factory Inc | プラスチックアンプル |
JP2014069856A (ja) | 2012-09-28 | 2014-04-21 | Yoshino Kogyosho Co Ltd | 合成樹脂製アンプル容器 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019181978A1 (ja) | 2018-03-23 | 2019-09-26 | テルモ株式会社 | 薬物充填済み合成樹脂製アンプルおよびそれに使用される合成樹脂製アンプル本体 |
JPWO2019181978A1 (ja) * | 2018-03-23 | 2021-03-25 | テルモ株式会社 | 薬物充填済み合成樹脂製アンプルおよびそれに使用される合成樹脂製アンプル本体 |
US11534370B2 (en) | 2018-03-23 | 2022-12-27 | Terumo Kabushiki Kaisha | Drug-filled synthetic resin ampule and synthetic resin ampule body used for same |
JP7374077B2 (ja) | 2018-03-23 | 2023-11-06 | テルモ株式会社 | 薬物充填済み合成樹脂製アンプルおよびそれに使用される合成樹脂製アンプル本体 |
JP2020059550A (ja) * | 2018-10-12 | 2020-04-16 | ロート製薬株式会社 | 樹脂製容器 |
JP7249123B2 (ja) | 2018-10-12 | 2023-03-30 | ロート製薬株式会社 | 樹脂製容器 |
JP2023063583A (ja) * | 2018-10-12 | 2023-05-09 | ロート製薬株式会社 | 樹脂製容器 |
JP7360238B2 (ja) | 2018-10-12 | 2023-10-12 | ロート製薬株式会社 | 樹脂製のブロー・フィル・シール成形容器 |
JP7425910B2 (ja) | 2018-10-12 | 2024-01-31 | ロート製薬株式会社 | 樹脂製容器及び樹脂製容器の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2017115752A1 (ja) | 2018-10-18 |
AU2016381925B2 (en) | 2021-02-18 |
EP3398581A1 (en) | 2018-11-07 |
US20180303710A1 (en) | 2018-10-25 |
JP7075761B2 (ja) | 2022-05-26 |
US10912713B2 (en) | 2021-02-09 |
EP3398581B1 (en) | 2022-08-10 |
EP3398581A4 (en) | 2019-09-11 |
AU2016381925A1 (en) | 2018-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6833730B2 (ja) | 接続及び容器システム | |
WO2017115752A1 (ja) | 自立可能な薬物充填済み合成樹脂製アンプル | |
JP6854781B2 (ja) | 接続及び容器システム | |
JP2016525396A (ja) | 医療用液体用のアンプル及びアンプルを製造する方法 | |
JP4041303B2 (ja) | 輸液用容器 | |
WO2017159832A1 (ja) | 薬物充填済み合成樹脂製アンプル | |
JP2021041183A (ja) | 接続及び容器システム | |
US11534370B2 (en) | Drug-filled synthetic resin ampule and synthetic resin ampule body used for same | |
JP2009286498A (ja) | 薬液容器 | |
JP4672957B2 (ja) | 薬液容器 | |
JP4956015B2 (ja) | 輸液用容器 | |
JPH04221567A (ja) | 医療用容器 | |
WO2019189278A1 (ja) | シリンジ用バレル組立体、包装体およびプレフィルドシリンジ | |
JP2007144231A (ja) | 複室容器 | |
JP2012035886A (ja) | 薬液容器 | |
JP5670781B2 (ja) | 輸液用容器 | |
JP2021108667A (ja) | 輸液用容器およびそれに用いられる薬剤収納用中空体 | |
JP2000175987A (ja) | 複室容器 | |
JP2004275465A (ja) | 薬液充填具 | |
JP2006081686A (ja) | バイアルポートおよびこれを備えた薬液キット | |
JP2005211336A (ja) | 導液具収納体 | |
JP2011206301A (ja) | 医療用容器用中空体、医療用容器用排出ポート、医療用容器用薬剤容器および医療用容器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16881727 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2017559182 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2016381925 Country of ref document: AU Date of ref document: 20161226 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2016881727 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2016881727 Country of ref document: EP Effective date: 20180730 |